Patient Clinical Trials

If you have a medical condition you may be eligible to participate in a patient clinical trial for the condition.  If you are interested, first register with us so we can contact you if we have a suitable patient clinical trial to recruit for.

We also conduct healthy volunteer clinical trials which may be of interest for people with no medical conditions.

Below are some of our Patient Clinical Trials.  For further information, please call us.

Oncology study

for non-small cell

lung cancer

You may be eligible if you:

  • have metastatic Non–Small Cell Lung Cancer (NSCLC)
  • have over-expression of a protein called PDL1
  • you have not received prior drug treatment.

 

 

Currently recruiting

No overnight stays required

14 visits over the first 12 weeks, then every 3 weeks

Oncology study for

all solid tumors and

pancreatic cancer

You may be eligible for Part 1 if you:

  • have a solid tumour that has progressed after standard treatment.

You may be eligible for Part 2 if you:

  • have metastatic pancreatic cancer

 

Currently recruiting

No overnight stays required

Weekly

outpatient

visits required

Oncology study

for GBM and other CNS tumours

You may be eligible if you:

  • have a CNS tumour such as GBM that has progressed after radiation and adjuvant TMZ

 

 

Currently recruiting

No overnight

stay

required

Varies from weekly to monthly

Immuno-oncology

study for all

solid tumours

You may be eligible for phase 1 enrolment if you:

  • have advanced or metastatic solid tumours and
  • have disease progression after treatment with available therapies, or intolerant to treatment, or refuse standard treatment.

You may be eligible for phase 2 enrolment (conducted after phase 1) if you:

  • have advanced or metastatic gastric cancer or squamous cell carcinoma of the head & neck and
  • have received only 1 prior chemotherapy regimen for advanced or metastatic disease.

 

Currently recruiting

No overnight stays required

8 visits for the first 12 weeks, then 1 visit every 2 weeks

Oncology study for

all soild tumors

and cervical cancer

You may be eligible for phase 1 enrolment if you:

  • have advanced or metastatic solid tumours and
  • have disease progression after treatment with available therapies or no standard therapy.

You may be eligible for phase 2 enrolment (commencing after phase 1 enrolment has been completed) if you:

  • have recurrent, unresectable, or metastatic cervical cancer and
  • have relapsed after a platinum-containing doublet administered for treatment of advanced disease

Currently recruiting

No overnight stays required

Weekly visits for the first 12 weeks, then 1 visit every 2 weeks